Covered recipient · General Payments record
JANET CONRAD
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner
General Payments · PY2021–2024
$1,821.54
- Reported across 92 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $606.30 | 27 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $220.48 | 11 |
| PFIZER INC. | $108.27 | 6 |
| Xeris Pharmaceuticals, Inc. | $97.37 | 1 |
| Amgen Inc. | $38.41 | 2 |
| Lilly USA, LLC | $38.13 | 2 |
| Astellas Pharma US Inc | $28.64 | 1 |
| Exact Sciences Corporation | $22.27 | 1 |
| Otsuka America Pharmaceutical, Inc. | $21.57 | 1 |
| Phathom Pharmaceuticals, Inc. | $16.22 | 1 |
| Seqirus USA Inc | $14.94 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (27)
Sorted by paying entity, then date · as published by CMS
Program year 2024 202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $14.83 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117530816 | CMS |
| Amgen Inc. | $23.58 | 11/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117530818 | CMS |
| Astellas Pharma US Inc | $28.64 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139516193 | CMS |
| Exact Sciences Corporation | $22.27 | 04/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114620872 | CMS |
| Lilly USA, LLC | $15.29 | 01/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135709396 | CMS |
| Lilly USA, LLC | $22.84 | 09/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135674720 | CMS |
| Novo Nordisk Inc | $19.99 | 02/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100560827 | CMS |
| Novo Nordisk Inc | $18.35 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100465250 | CMS |
| Novo Nordisk Inc | $13.97 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100295126 | CMS |
| Novo Nordisk Inc | $2.61 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100379137 | CMS |
| Novo Nordisk Inc | $14.58 | 07/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100498149 | CMS |
| Novo Nordisk Inc | $18.84 | 09/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100408158 | CMS |
| Novo Nordisk Inc | $17.26 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100331068 | CMS |
| Novo Nordisk Inc | $20.01 | 09/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100545170 | CMS |
| Novo Nordisk Inc | $82.27 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100339182 | CMS |
| Novo Nordisk Inc | $9.47 | 11/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100351254 | CMS |
| Novo Nordisk Inc | $3.13 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100362143 | CMS |
| Otsuka America Pharmaceutical, Inc. | $21.57 | 02/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119048782 | CMS |
| PFIZER INC. | $19.25 | 04/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132003646 | CMS |
| PFIZER INC. | $22.08 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131610162 | CMS |
| PFIZER INC. | $13.97 | 07/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132010980 | CMS |
| PFIZER INC. | $20.91 | 09/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132030327 | CMS |
| PFIZER INC. | $16.10 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131259426 | CMS |
| PFIZER INC. | $15.96 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131129968 | CMS |
| Phathom Pharmaceuticals, Inc. | $16.22 | 11/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151157023 | CMS |
| Seqirus USA Inc | $14.94 | 09/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125628326 | CMS |
| Xeris Pharmaceuticals, Inc. | $97.37 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144627940 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.